Document is current

Article History

Accepted: 7 July 2021

First Online: 27 October 2021

Declarations

:

: This study was funded by Galderma.

: JT has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from Almirall, Boots Walgreens, Bausch, Cipher, Galderma, L'Oreal, and Sun. SB has acted as an advisor for AbbVie Deutschland GmbH & Co, Actelion Pharmaceuticals GmbH, Almirall-Hermal GmbH, Amgen GmbH, Celgene GmbH, Galderma Laboratorium GmbH, Janssen-Cilag GmbH, Leo Pharma GmbH, Lilly Deutschland GmbH, Menlo Therapeutics, MSD Sharp & Dohme GmbH, Novartis Pharma GmbH, Pfizer Pharma GmbH, Sanofi-Aventis Deutschland GmbH, and UCB Pharma GmbH, and has received speaker honorarium from Novartis Pharma GmbH, AbbVie, MSD, Pfizer, Janssen-Cilag, La Roche-Posay, Actelion, GSK, BMS, Celgene, Almirall, and Hexal-Sandoz. FCB has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from Almirall, Cassiopea, Foamix Pharmaceuticals, Galderma, and Ortho Dermatologics. RC is an employee of Galderma. JH has acted as an advisor, consultant, and/or speaker and received honoraria from Almirall, BioPharmX, Cassiopeia, Cutanea, Cutera, Dermira, EPI Health, Galderma, La Roche-Posay, Ortho Dermatologics, Sol Gel, Sun, and Vyne. AH has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from Allergan, Cassiopea, Galderma, GSK, La Roche-Posay, Novan, Ortho Dermatologics, Regeneron Sanofi, and Vyne. EL has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from AbbVie, Aclaris Therapeutics Inc., Allergan Inc., Almirall, AstraZeneca, Athenix, Biopelle Inc., BioPharmX, Biorasi LLC, BMS, Brickell Biotech Inc., Cassiopea S.p.A., Celgene, Cellceutix, ChemoCentryx, Cutanea Life Sciences, Demira, Dow Pharmaceutical Sciences Inc., Dr Reddy's Laboratory, Eli Lilly and Company, Gage Development Company LLC, Galderma Laboratories L.P., Galderma USA, Hovione, Kadmon Corporation LLC, La Roche-Posay, LEO Pharma, Medimmune, Menlo Therapeutics, Moleculin LLC, Neothetics, Nielsen Holdings N.V,, Novartis, Ortho Dermatologics, Pfizer Inc., Promius Pharma LLC, Sebacia Inc., Sienna Labs Inc., SkinCeuticals LLC, Sol-Gel Technologies, UCB, and Valeant Pharmaceuticals North America LLC. AL has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from Galderma, GSK, L’Oreal, La Roche-Posay, Origimm, Leo Pharma, and Proctor & Gamble. MR has acted as an advisor and/or speaker and received honoraria from Eucerin, Galderma, Johnson & Johnson, and Leo Pharma. JW has acted as an advisor, consultant, investigator, and/or speaker and received grants/honoraria from Almirall, Bausch, Cassiopea, Cutera, EPI Health, Foamix, Galderma, and Ortho Dermatologics. BD has acted as an advisor, consultant, and/or speaker and received honoraria from BMS, Galderma, La Roche-Posay, Merck Serono, Pierre Fabre, and Sanofi.

: A copy of the study questionnaire is available on request. Individual data cannot be shared for privacy reasons.

: Not applicable.

: JT, BD, RC: made substantial contributions to the conception or design of the work and the analysis or interpretation of data; drafted the work and revised it critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. SB, FC-B, JH, AH, EL, AL, MR, JW: made substantial contributions to the analysis and interpretation of data; revised the work critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

: The Kantar Independent Review Board/Ethics Committee conducted a detailed review of the study and reached a favorable opinion on the 30th of September 2021 (retrospective approval).

: All participants provided informed consent prior to participation.

: Not applicable.